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linguistic differences between China and North America or Western Europe where 
PROs tend to be developed. The objective of this study was to identify some of the 
linguistic and cultural differences between English and Mandarin as well as cultural 
differences between North America and Western Europe and China. METHODS: Five 
questionnaires relating to varied health states were reviewed and the cultural and lin-
guistic issues arising during different stages of the translation process were examined. 
RESULTS: Numerous cultural and linguistic issues became apparent throughout the 
review, including: 1)Mandarin does not employ superlatives so “the worst” was 
translated as “extremely bad”; 2)some patients did not understand how to complete 
a VAS although the words themselves were clear; 3) there is no speciﬁc beneﬁt of 
“disability compensation” in China—this is a general beneﬁt which can include pen-
sions; 4) Private clinics where respondents receive acupuncture and massage are very 
common in China so additional categories had to be added to a resource utilisation 
measure; 5) in Mandarin questions cannot begin with “how often;” instead they are 
phrased “does it often”; 6) with response options such as “never”, “sometimes”, 
appropriate responses can still be chosen; and 6) Low levels of obesity in China made 
recruitment for the linguistic validation of an obesity measure difﬁcult. CONCLU-
SIONS: An increasing number of clinical trials take place in China. The issues raised 
above show some of the linguistic differences between English and Mandarin, and 
cultural differences between Western Europe / North America and China. These and 
other issues are important to consider when selecting, developing and translating 
measures for use in China.
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OBJECTIVES: The purpose of this study was to explore the incremental cost-effective-
ness ratio (ICER) ranges of variant health interventions. METHODS: We performed 
the systematic review of cost-effectiveness studies about health interventions. Com-
prehensive literature review was conducted using MEDLINE and EMBASE with a 
publication date before March 24, 2009. We selected literatures based on the follow-
ing criteria; 1) written in the English and Korean languages; 2) contained information 
on interventions relevant to diseases or health problems; 3) reported cost per year of 
life saved or contained sufﬁcient information to calculate this ratio; 4) study methodol-
ogy related to economic evaluations such as cost-utility analysis (CUA) and cost-
effectiveness analysis (CEA), and 5) contained information whether the health 
intervention is cost-effective or not. We calculated the mean of reported ICER of major 
therapeutic area and major countries from all selected literature and extracted implicit 
ICER threshold based on the author’s conclusion about cost-effectiveness. The value 
of ICER in each literature was converted to 2008 value reﬂecting exchange rate and 
price index. RESULTS: A total of 3662 articles were originally identiﬁed from the 
planned searching strategy. 1466 among them were ﬁnally included to calculate ICER 
range after abstract review and/or full text review. Two independent reviewers worked 
to select relevant articles and extract data. Mean incremental cost per Quality-
adjusted-life-years-gained or Life-years-gained were US$130,514, US$25,446, 
US$30,448, US$70,420 for cancer, cardiovascular diseases, endocrine disease, and 
musculoskeletal disease, respectively. The ICER according to countries were also 
varied a lot. If we see the author’s judgment on cost-effectiveness, some interventions 
were recommended as cost-effective even in the case ICER were approximately 
US$80,000, US$75,000, US$200,000 for UK, Canada, and USA. CONCLUSIONS: 
The judgment on cost-effective interventions could be different according to countries 
and disease. It tends to have higher ICER in severe disease and in developed 
countries.
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OBJECTIVES: The National Institute for Health and Clinical Excellence (NICE) has 
expressed a preference for the EQ-5D in cost-effectiveness analyses. Directly eliciting 
EQ-5D scores for speciﬁc disease states can be cumbersome and expensive. Use of 
disparate sources of utility scores by different researchers introduces variability and 
potential bias. Developing an “off-the-shelf” catalogue provides easily accessible EQ-
5D scores from a single-source general population. The current study aims to develop 
a catalogue of EQ-5D scores for chronic conditions using U.K. preferences. 
METHODS: The Medical Expenditure Panel Survey (MEPS), a general population 
survey in the U.S., was pooled (2000, 2001, 2002 and 2003) to create a sample of 
79,524 adults with valid EQ-5D responses. The EQ-5D was administered via a paper 
and pencil self-administered questionnaire (SAQ) to adults q 18 years. UK tariffs for 
the EQ-5D (Dolan) were applied to questionnaire responses. Chronic conditions were 
classiﬁed by ICD-9 codes and Clinical Classiﬁcation Category (CCC) codes. Ordinary 
least squares (OLS), Tobit, and censored least absolute deviations (CLAD) regression 
methods were used to estimate the marginal disutility of each condition controlling 
for age, comorbidity, gender, race, ethnicity, income and education. RESULTS: A 
catalogue of several hundred statistically signiﬁcant marginal disutility (EQ-5D) scores 
for each chronic ICD-9 and CCC code are presented and compared. Marginal disutili-
ties for each condition represent the isolated impact of the condition after controlling 
for comorbidity and covariates. CONCLUSIONS: This research provides a catalogue 
of “off-the-shelf” UK-based preference scores for the EQ-5D based on a single-source 
general population survey. Scores and marginal disutilities for a wide variety of 
chronic ICD-9 and CCC codes can be used to estimate QALYs in cost-effectiveness 
analyses in the UK. Although the preference function was derived from a U.K. popula-
tion sample, there are limitations associated with using a US survey to develop the 
condition-speciﬁc questionnaire responses.
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OBJECTIVES: Time trade-off (TTO) utilities are traditionally elicited through face-
to-face interviews, but these may be costly and time-consuming. We recruited a sample 
of restless-legs syndrome (RLS) sufferers using an online panel and administered an 
online version of TTO. METHODS: Members of a UK online marketing research 
panel were invited to participate, subject to conﬁrmation of RLS diagnosis. The 
recruitment target was a minimum of 50 subjects in each of 4 severity categories based 
on the International Restless Legs Syndrome (IRLS) score. The TTO interface was 
adapted from a widely used, validated protocol for face-to-face administration. We 
explored associations between self-rated health according to IRLS, EQ-5D (UK tariff) 
and the online TTO. RESULTS: Over 15 days, 287 eligible participants (57, 90, 90 
and 50 in mild, moderate, severe and very severe categories respectively) were 
recruited. Mean EQ-5D utilities by severity category were 0.80, 0.67, 0.51 and 0.29. 
275 participants agreed to complete the TTO. Twenty-four percent were unwilling to 
sacriﬁce any life expectancy in their current state of health although they preferred a 
life in full health for a similar duration. Mean TTO utilities by severity category were 
0.83, 0.82, 0.75 and 0.56. The correlation between EQ-5D and TTO utilities was 
0.354 (p  0.0001). TTO utilities were associated with EQ-5D utilities independently 
of IRLS score. Neither EQ-5D nor TTO utilities were signiﬁcantly associated with age 
or gender, after controlling for IRLS score. Social class was signiﬁcantly associated 
with EQ-5D, but not with TTO. CONCLUSIONS: Online recruitment enabled rapid 
recruitment of subjects with RLS. Correlations between TTO utilities and other vari-
ables were consistent with expectations, but the number of non-traders seemed high. 
Comparative studies with face-to-face TTO would be desirable, as the online approach 
seems an attractive solution to allow primary utility elicitation when time or cost 
constraints preclude a face-to-face survey.
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In ﬁrst EQ-5D valuation studies based on time-trade-off (TTO) respondents valued 
13 health states. OBJECTIVES: To evaluate the possible bias resulting from expanding 
the TTO experiment to 23 states per respondent. METHODS: In Polish EQ-5D valu-
ation study, 7351 TTO valuations from 321 respondents were available before exclu-
sions. First, we tested whether the mean valuation for each health state differed when 
it was valued in the middle of the experiment (6th-17th state) or at the end of the 
experiment (18th-23rd state). A series of t-tests for the equality of means and equality 
of variances was performed for each health state separately. To control for the multiple 
hypotheses testing the Hölm-Bonferroni correction was used. Moreover, to test the 
stability of regression coefﬁcients within TTO experiment, Chow tests were per-
formed: with the whole sample divided into two or three subgroups. In both cases the 
basic model with no interaction terms was used. RESULTS: The comparison of health 
state values when assigned during the middle of the experiment or at the end showed 
no statistically signiﬁcant differences neither in mean nor in variance (the smallest P-
values for means and variances comparison were equal to 0.0161 and 0.0060 respec-
tively, with Hölm-Bonferroni threshold of 0.0023). Regression coefﬁcients of two 
parsimonious models built on valuations 1st–17th (n  5009) or 18th–23rd (n  1760), 
did not differ signiﬁcantly in Chow test (p  0.5521). Similarly, regression coefﬁcients 
of three parsimonious models built on valuations 1st–5th (n  1461), 6th–17th (n  
3548) or 18th–23rd, did not differ (p  0.4334), neither. CONCLUSIONS: As we 
found no systematic change neither in mean, nor in variance, nor in model parameters 
due to TTO experiment extension, we believe there is no risk of a bias or efﬁciency 
decrease in the model estimation. The present study supports the use of more health 
states per respondent in TTO valuations than previously thought.
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DIFFICULTIES WITH THE APPLICATION OF PRO MEASURES TO 
CULTURES OUTSIDE OF WESTERN EUROPE AND NORTH AMERICA IN 
MULTI-NATIONAL TRIALS
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OBJECTIVES: The majority of PRO measures are developed using a sequential rather 
than a cross-cultural approach and have been developed in the US and/or UK. When 
using these measures in multi-national trials, the assumption is made that the trans-
lated measure is acceptable for use in a multi-national trial, providing the translation 
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has been conducted in a rigorous manner and that linguistic validation interviews have 
been conducted in the target country. The objective of this study was to ascertain 
whether there are particular areas of concern with respect to using these PROs outside 
of North America and Western Europe. METHODS: Specialists in outcomes research 
from nine countries within Eastern Europe, Asia and Africa completed a questionnaire 
and interview about difﬁculties which occur with the cultural relevance of concepts 
included in PROs and other health questionnaires. RESULTS: Numerous cultural and 
linguistic issues became apparent, including: 1)The concept of witchcraft is particu-
larly important in many places in Africa; 2)Japanese people have a tendency to be 
more positive about their disease or emotional health which may affect their responses 
to measures; 3)the concept of family is much more important in some countries, e.g. 
Malaysia and Ukraine; 4) the idea of ‘God’s will’ is particularly important to the way 
people think about health in Saudi Arabia and Sudan; 5)In Saudi Arabia and Sudan 
women rarely play sports (a topic sometimes included in PRO measures); and ques-
tions about alcohol use cannot be used in Islamic countries. CONCLUSIONS: A 
number of issues should be considered during the sequential development of PRO 
measures. This can be achieved using an extended translatability check which would 
include representatives from countries outside of North America and Western Europe 
to help bridge the gap between the cultural speciﬁcity of a sequentially developed 
measure and a cross-culturally developed measure.
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OBJECTIVES: Qualitative research methods are pivotal to PRO research and the 
importance of these methods has been highlighted by the FDA draft guidance. The 
objective of this study was to conduct a review of qualitative methods used in health 
and social research, to evaluate the methods for application in PRO research, and to 
develop a methods matrix to enable the selection of the most appropriate methods in 
a given situation. METHODS: A search was conducted in Medline to identify methods 
of qualitative data collection and analysis in general, and to identify those methods 
applied to PRO research since the publication of the FDA draft guidance in February 
2006. Qualitative research methods falling were evaluated according to the require-
ments for valid and reliable PRO research and a methods matrix was prepared. 
RESULTS: There are a wide variety of methods utilised in health and social research, 
which are in the broad category of qualitative methods for data collection and analysis. 
With some approaches, e.g. thematic analysis and grounded theory, there is a need 
for a tightening of deﬁnition in order to reduce some of the ambiguity around methods. 
In PRO research qualitative methods are used in concept exploration, selection of 
PROs, translation of PROs, migration from paper to ePRO, and development/modi-
ﬁcation of PROs (content validity evidence) among other areas. The results matrix 
identiﬁes which qualitative methods are the most appropriate for use in speciﬁc areas 
of PRO research. CONCLUSIONS: The ways in which qualitative research methods 
are applied in PRO research are varied, with some emergence in recent years of alterna-
tive theoretical approaches. The results matrix provides a useful and practical refer-
ence to enable selection of a range of qualitative methods for application to solve 
speciﬁc PRO research requirements.
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OBJECTIVES: Since December 2007 the Zarit Burden Interview is centrally distrib-
uted under the control and with the collaboration of its developer. Our objective was 
to demonstrate the efﬁcacy of such process by comparing the information about the 
instrument translations retrieved through a classical literature search with the one 
provided through the centralized distribution process. METHODS: We searched 
Medline, Embase and PsychInfo with the keywords: Zarit, caregiver, burden, inter-
view, translation, language, and validation. The articles were tabulated according to 
the language used in the study, the country of reference, and the number of teams in 
each country using the ZBI. The search procedure and the information retrieved were 
then compared with those obtained through the distribution centre. RESULTS: The 
literature search resulted in 106 articles of which 15 concerned ZBI derivatives, and 
9 the original US version. Out of the remaining papers, we identiﬁed 59 local teams 
corresponding to 20 countries and 12 languages. Only 9 articles concerned the psy-
chometric validation of the ZBI in different countries. For most countries, there was 
no way to check item correspondence across translations or to identify whether one 
version was the same one used across all teams, increasing the doubt of having multiple 
translations for one country and language (e.g. Spain—n  9 teams). There was no 
clear information about the translations’ validation status. Contrarily, the information 
provided through the distribution center led to the quick identiﬁcation of 33 transla-
tions, certiﬁed by the developer. Information about copyright, conditions of use and 
methodology of translation was provided. CONCLUSIONS: Findings indicate that 
information retrieved through a centralized distribution is more reliable and less time 
consuming than a search using classical tools. Promoting a controlled centralized 
system with instrument developers’ input will facilitate access to comprehensive infor-
mation, and will contribute to meet health authorities’ requirements of evidence-based 
information.
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OBJECTIVES: Treatment Satisfaction (SATMED-Q) is a generic PRO instrument 
measuring Treatment satisfaction with medicines in chronic health conditions, origi-
nally developed in Spanish, with known good psychometric properties. A new English 
version has been produced and linguistically tested. METHODS: The original version 
was translated into English by the Spanish speaking authors and used as reference 
for further versions. Two independent English native translators created two trans-
lated versions and a harmonised version was produced. The harmonized version 
was tested by three clinicians in a pilot sample of 20 chronic patients. Suggested 
modiﬁcations were introduced and a ﬁnal version was shaped. The ﬁnal version was 
compared with the reference translation and back-translated into Spanish by two other 
independent translators native in Spanish. RESULTS: Meaningful differences were 
found between the two translations, especially when referring to undesirable effects, 
medication-treatment, disease-illness-medical condition, leisure and labour. Slight dif-      
ferences were also found on the words used to anchor the Likert response scales. 
Suggestions from the pilot sample advised to introduce examples accompanying ques-
tions about physical activity, free time activities, daily activities and personal hygiene, 
in order to illustrate questions. Nevertheless, the questionnaire was found easy to 
answer and to understand, and completion times were similar to those found with 
the original instrument. CONCLUSIONS: An English version of the SATMED-Q 
questionnaire is now available with linguistic validity ensured. Although psychometric 
properties should now be assessed, this new version allows beginning the cultural 
validation process and can be safely used as a bridge instrument towards other 
languages.
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OBJECTIVES: This study performed meta-analysis examining the correlations of 
measurements of medication adherence (medication event monitoring system [MEMS] 
and self-reported questionnaires) using published study reports. METHODS: The lit-
erature search was performed from 1980–2009 using PubMed, PubMed In Process 
and Non-Indexed, OVID MEDLINE, PsycINFO (EBSCO), CINAHL (EBSCO), OVID 
HealthStar, EMBASE (Elsevier), and Cochrane Databases. The following search terms 
were used: patient compliance, medication adherence, treatment compliance, drug 
monitoring, drug therapy, electronic, digital, computer, monitor, monitoring, drug, 
drugs, pharmaceutical preparations, compliance, and medications. Studies were 
included if the correlation coefﬁcients [Pearson correlation coefﬁcient (rp) or Spearman 
rank correlation coefﬁcient (rs)] between adherences measured by both MEMS and 
self-reported questionnaires were available or could be calculated. A meta-analysis 
was conducted to pool the correlation coefﬁcients using random-effect model. 
RESULTS: A total of 11 studies (N  1684 patients) met the inclusion criteria. The 
mean of adherence measured by MEMS was 74.9%, ranging from 53.4% to 92.9% 
and 84.0% by self-reported questionnaire, from 76.5% to 93.5%. The correlation 
between adherence measured by MEMS and self-report questionnaires ranged from 
0.24 to 0.87. Seven (63.6%) articles reported rp values whereas 4 studies (36.4%) had 
rs values. The combined effect size for 11 studies was 0.45 (p  0.001, 95% conﬁdence 
interval [95% CI]: 0.34–0.56). The subgroup meta-analysis on the studies reporting 
rp and rs correlation revealed the effect size 0.46 (p  0.001, 95% CI: 0.33–0.59) and 
0.43 (p  0.001, 95% CI: 0.23–0.64), respectively. CONCLUSIONS: The correlation 
between adherence measured by MEMS and self-reported questionnaires tends to be 
moderate. Therefore, self-reported questionnaires give good estimate of patient medi-
cation adherence. However, MEMS and self-reported questionnaire should be used 
complementary to get accurate measure for patient adherence.
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OBJECTIVES: Over the last few decades, many theories have been developed for the 
basic needs of human beings. Speciﬁcally, Maslow’s hierarchical model offered a 
sounder theoretical basis for theory of needs. The aim of this research was to examine 
whether the items of quality of life (based on the WHOQOL-BREF Taiwan version)             
ﬁt with the framework of Maslow’s hierarchy of needs. METHODS: This study used   
13,008 participants aged from 20 to 65 from the 2001 National Health Interview 
Survey (NHIS) in Taiwan. The items of the WHOQOL-BREF were categorized accord-
ing to Maslow’s ﬁve hierarchical levels of needs: physiological needs, safety needs,    
love and belonging needs, esteem needs and self-actualization needs. Structural equa- 
tion modeling (SEM) was conducted to test the hierarchical model. RESULTS: The 
results showed that the model of Maslow’s hierarchy of needs did not ﬁt the real data 
well if all of the items of the WHOQOL-BREF Taiwan version were used. However,     
after deleting several misﬁt items, the model can be ﬁtted well. In general, the deleted           
items were comparatively far from the deﬁnition of Maslow’s hiererchical model. 
CONCLUSIONS: The study showed that partial items from the WHOQOL-BREF ﬁt          
